Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/01/04 09:42:49」(JST)
wiki en
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. ヘパリンおよびLMWヘパリン：用量および副作用 heparin and lmw heparin dosing and adverse effects
- 2. ST上昇型心筋梗塞における抗凝固療法 anticoagulant therapy in acute st elevation myocardial infarction
- 3. 静脈血栓塞栓症に対する低分子ヘパリン low molecular weight heparin for venous thromboembolic disease
- 4. 幼児および小児における静脈血栓症および血栓塞栓症の診断および治療 diagnosis and treatment of venous thrombosis and thromboembolism in infants and children
- 5. Treatment, prognosis, and follow-up of acute pulmonary embolism in adults
English Journal
- Sustained release of tissue factor following thrombosis of lower limb trauma.
- Walenga JM1, Kaiser PC2, Prechel MM3, Hoppensteadt D4, Jeske WP3, Misselwitz F5, Bacher P6, Lassen MR7, Fareed J4.
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.Clin Appl Thromb Hemost.2014 Oct;20(7):678-86. doi: 10.1177/1076029614545212. Epub 2014 Aug 12.
- This study was undertaken to provide evidence for the mechanism of venous thromboembolism (VTE) in healthy patients with minor lower limb injury (fracture; Achilles tendon rupture) that was medically managed with plaster cast/brace immobilization. The Plaster Cast clinical trial provided a unique op
- PMID 25115761
- Are pharmacological properties of anticoagulants reflected in pharmaceutical pricing and reimbursement policy? Out-patient treatment of venous thromboembolism and utilization of anticoagulants in Poland.
- Bochenek T1, Czarnogorski M, Nizankowski R, Pilc A.
- European review for medical and pharmacological sciences.Eur Rev Med Pharmacol Sci.2014 Jun;18(11):1649-56.
- OBJECTIVES: Pharmacotherapy with vitamin K antagonists (VKA) and low-molecular-weight heparins (LMWH) is a major cost driver in the treatment of venous thromboembolism (VTE). Major representatives of anticoagulants in Europe include: acenocoumarol and warfarin (VKA), enoxaparin, dalteparin, nadropar
- PMID 24943977
- Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children.
- Brandão LR1, Shah N, Shah PS.
- The Cochrane database of systematic reviews.Cochrane Database Syst Rev.2014 Mar 10;3:CD005982. doi: 10.1002/14651858.CD005982.pub2.
- BACKGROUND: The prevalence of children diagnosed with deep vein thrombosis or pulmonary embolism has been increasing in the last decade. The most common thrombosis risk factor in neonates, infants and children is the placement of a central venous catheter (CVC). To date, it is unknown if the practic
- PMID 24615288
Japanese Journal
- Thromboprophylaxis with Reviparin in a Patient with Acquired Hemophilia
- International journal of hematology 81(2), 176-177, 2005-02-15
- NAID 10014372619
- ２種の低分子ヘパリンを透析患者に使用した際の凝血学的特性の比較―薬物動態的検討―
- 日本透析医学会雑誌 37(10), 1875-1880, 2004
- NAID 130003721776
- Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization
- N Engl J Med 347, 726-730, 2002
- NAID 30022557651
Related Links
- 1. Drugs. 2001;61(8):1185-209. Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism. Wellington K(1), McClellan K, Jarvis B. Author information: (1)Adis International Limited, Mairangi ...
- Tolerability Clinical trials have shown that subcutaneous reviparin is well tolerated when used for the prophylaxis and treatment of thromboembolism. Comparative data indicate that its tolerability profile is at least as good as those of ...
Related Pictures
★リンクテーブル★
| リンク元 | 「レビパリン」 |
| 拡張検索 | 「reviparin sodium」 |